These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32086528)

  • 1. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
    Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
    Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
    Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
    Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.
    Leong WZ; Tan SH; Ngoc PCT; Amanda S; Yam AWY; Liau WS; Gong Z; Lawton LN; Tenen DG; Sanda T
    Genes Dev; 2017 Dec; 31(23-24):2343-2360. PubMed ID: 29326336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin looping defines expression of TAL1, its flanking genes, and regulation in T-ALL.
    Zhou Y; Kurukuti S; Saffrey P; Vukovic M; Michie AM; Strogantsev R; West AG; Vetrie D
    Blood; 2013 Dec; 122(26):4199-209. PubMed ID: 24200685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enhancer RNA
    Tan SH; Leong WZ; Ngoc PCT; Tan TK; Bertulfo FC; Lim MC; An O; Li Z; Yeoh AEJ; Fullwood MJ; Tenen DG; Sanda T
    Blood; 2019 Jul; 134(3):239-251. PubMed ID: 31076442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia.
    Kloetgen A; Thandapani P; Ntziachristos P; Ghebrechristos Y; Nomikou S; Lazaris C; Chen X; Hu H; Bakogianni S; Wang J; Fu Y; Boccalatte F; Zhong H; Paietta E; Trimarchi T; Zhu Y; Van Vlierberghe P; Inghirami GG; Lionnet T; Aifantis I; Tsirigos A
    Nat Genet; 2020 Apr; 52(4):388-400. PubMed ID: 32203470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human β-globin enhancer LCR HS2 plays a role in forming a TAD by activating chromatin structure at neighboring CTCF sites.
    Kim J; Kang J; Kim YW; Kim A
    FASEB J; 2021 Jun; 35(6):e21669. PubMed ID: 34033138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia.
    Luo H; Zhu G; Eshelman MA; Fung TK; Lai Q; Wang F; Zeisig BB; Lesperance J; Ma X; Chen S; Cesari N; Cogle C; Chen B; Xu B; Yang FC; So CWE; Qiu Y; Xu M; Huang S
    Mol Cell; 2022 Feb; 82(4):833-851.e11. PubMed ID: 35180428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the β-globin locus.
    Kang J; Kim YW; Park S; Kang Y; Kim A
    FASEB J; 2021 Aug; 35(8):e21768. PubMed ID: 34245617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia.
    Tan TK; Zhang C; Sanda T
    Int J Hematol; 2019 Jan; 109(1):5-17. PubMed ID: 30145780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
    Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
    J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX1 is required for oncogenic
    Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
    Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute depletion of CTCF directly affects MYC regulation through loss of enhancer-promoter looping.
    Hyle J; Zhang Y; Wright S; Xu B; Shao Y; Easton J; Tian L; Feng R; Xu P; Li C
    Nucleic Acids Res; 2019 Jul; 47(13):6699-6713. PubMed ID: 31127282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
    Smith C; Goyal A; Weichenhan D; Allemand E; Mayakonda A; Toprak U; Riedel A; Balducci E; Manojkumar M; Pejkovska A; Mücke O; Sollier E; Bakr A; Breuer K; Lutsik P; Hermine O; Spicuglia S; Asnafi V; Plass C; Touzart A
    Haematologica; 2023 May; 108(5):1259-1271. PubMed ID: 36632736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
    Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
    Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.
    Smits WK; Vermeulen C; Hagelaar R; Kimura S; Vroegindeweij EM; Buijs-Gladdines JGCAM; van de Geer E; Verstegen MJAM; Splinter E; van Reijmersdal SV; Buijs A; Galjart N; van Eyndhoven W; van Min M; Kuiper R; Kemmeren P; Mullighan CG; de Laat W; Meijerink JPP
    Cell Rep; 2023 Apr; 42(4):112373. PubMed ID: 37060567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia.
    Ong JZL; Tan TK; Wang L; Tan SH; Sanda T
    Haematologica; 2024 May; 109(5):1359-1372. PubMed ID: 37855064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTCF-mediated genome organization and leukemogenesis.
    Qiu Y; Huang S
    Leukemia; 2020 Sep; 34(9):2295-2304. PubMed ID: 32518417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTCF boundary remodels chromatin domain and drives aberrant
    Luo H; Wang F; Zha J; Li H; Yan B; Du Q; Yang F; Sobh A; Vulpe C; Drusbosky L; Cogle C; Chepelev I; Xu B; Nimer SD; Licht J; Qiu Y; Chen B; Xu M; Huang S
    Blood; 2018 Aug; 132(8):837-848. PubMed ID: 29760161
    [No Abstract]   [Full Text] [Related]  

  • 20. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
    Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
    Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.